We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Uniqure Nv
12 own
14 watching
Current Price
$13.99
$0.76
(5.74%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
976.47M
52-Week High
19.18000
52-Week Low
3.73000
Average Volume
2.39M
Dividend Yield
--
P/E Ratio
5.0703
Market Capitalization976.47M52-Week High19.1800052-Week Low3.73000Average Volume2.39MDividend Yield--P/E Ratio5.0703What does the Uniqure Nv do?
Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
Read More
How much money does Uniqure Nv make?
News & Events about Uniqure Nv.
Business Wire
1 year ago
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. (uniQure or the Company) (NASDAQ: QURE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or...
Business Wire
1 year ago
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of uniQure N.V. (uniQure or the Company) (NASDAQ: QURE) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or...
PR Newswire
1 year ago
Thinking about buying stock in bluebird bio, Uniqure, Terawulf, Metaworks Platforms, or Nikola Corp? Thinking about buying stock in bluebird bio, Uniqure, Terawulf, Metaworks Platforms, or Nikola Corp? PR Newswire NEW YORK, June 21, 2023 NEW YORK, June 21, 2023 /PRNewswire/ -- InvestorsObserver...
PR Newswire
1 year ago
Thinking about buying stock in Eightco Holdings, Uniqure, Atento, Red Cat Holdings, or Opendoor Technologies? Thinking about buying stock in Eightco Holdings, Uniqure, Atento, Red Cat Holdings, or Opendoor Technologies? PR Newswire NEW YORK, June 21, 2023 NEW YORK, June 21, 2023 /PRNewswire...
Globe Newswire
1 year ago
LEXINGTON, Mass. and AMSTERDAM, June 16, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the grant of inducement equity awards to Jeannette Potts, the Companys newly hired ...
Frequently Asked Questions
Frequently Asked Questions
What is Uniqure Nv share price today?
Can Indians buy Uniqure Nv shares?
How can I buy Uniqure Nv shares from India?
Can Fractional shares of Uniqure Nv be purchased?
What are the documents required to start investing in Uniqure Nv stocks?
What is today’s traded volume of Uniqure Nv?
What is today’s market capitalisation of Uniqure Nv?
What is the 52-Week High and Low Range of Uniqure Nv?
What percentage is Uniqure Nv down from its 52-Week High?
What percentage is Uniqure Nv up from its 52-Week Low?
Current Price
$13.99
$0.76
(5.74%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.